Biograil

company

About

Biograil is a biotech company manufacturing an oral device for delivery of biologics

  • 1 - 10

Details

Last Funding Type
Seed
Last Funding Money Raised
€3M
Industries
Biotechnology,Manufacturing
Founded date
Jan 1, 2019
Number Of Employee
1 - 10
Operating Status
Active

Biograil, founded in 2019 and led by CEO Karsten Lindhardt, is using injection molding to manufacture a device contained in a standard size capsule able to deliver active substances into the gastrointestinal wall. The Biograil device avoids mechanical moving components and makes use of the body’s own peristaltic forces to facilitate the delivery of the biologic efficiently into the gastrointestinal wall.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
€3M
Biograil has raised a total of €3M in funding over 2 rounds. Their latest funding was raised on Jan 17, 2020 from a Seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 17, 2020 Seed €3M 3 Detail

Investors

Number of Lead Investors
Number of Investors
3
Biograil is funded by 3 investors. Verve Ventures and Megatrend Invest are the most recent investors.
Investor Name Lead Investor Funding Round
Verve Ventures Seed
Megatrend Invest Seed
Swiss Investment group Seed